Global Bone and Joint Health Supplement Market is expected to register a CAGR of approx. 8% over the period of 2022-2028.  The bone and joint health supplements market is rising due to the increasing prevalence of bone-related problems like osteoporosis, rheumatoid arthritis, etc. around the globe.  For instance, in 2022, according to very wealth.com, More than 22% of American adults (over 52.5 million people) have arthritis or another rheumatic condition diagnosed by a doctor. 7.3% of people aged 18-44 have doctor-diagnosed arthritis; 30.3% of people aged 45-64; and 49.7% of those over 65, and by 2030, the number of people with arthritis (adults 18 years and older) is expected to rise to 67 million. Owing to these glaring statistics the demand for bone and joint health supplements is anticipated to grow in the forthcoming years as they are safe and help in making strong bones. According to UnivDatos Market Insights (UMI)’ research report “global bone and joint health supplements market”, the market is expected to witness a robust growth during the forecast period 2022-2028F. Moreover, several innovations in the nutritional supplements sector are fueling the demand for the bone and joint health supplements market. Furthermore, the changing lifestyles also increasing the joint discomfort in the young generation is expected to drive the market for bone and joint health supplements market in the coming years.

Unlock The Table of Content, And Request a Sample Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=28047

Based on the ingredient types, the market is fragmented into vitamins minerals, amino acids, botanical supplements, and others. The vitamins minerals segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to the growing adoption of healthy lifestyles, increasing life expectancy, and rising focus on active lifestyles.

Based on the end-users, the market is fragmented into men, women, and children. The women segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. Women's bones are smaller and thinner than men. When menopause sets in, oestrogen, a hormone in women that protects bones, begins to drop off quickly, leading to bone loss due to which bone supplements are necessary for women and likely to boost the growth of the segment.

North America witnessed extensive growth

For a better understanding of the market adoption of the bone and joint health supplements market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the bone and joint health supplements industry owing to the high demand from the elderly population due to joint discomfort and the increasing health-conscious population and their inclination toward functional food and beverages.

For More Informative Information, Please Visit Us – https://univdatos.com/report/bone-and-joint-health-supplements-market/

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the global bone and joint health supplements market are Bayer AG, Procter Gamble Co, Amway India Enterprises Pvt. Ltd., BASF SE, Archer-Daniels-Midland Co, Pfizer Inc, Reckitt Benckiser Group Plc, Vita Life Sciences Limited, Arazo Nutrition, Glanbia plc Several MA’s along with partnerships have been undertaken by these players to boost their presence in different regions.

“Global Bone and Joint Health Supplements Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on different parameters. This will help companies in the formulation of go-to-market strategies and identifying the blue ocean for its offerings.        

Market Segmentations:

1. By Form (Soft Gels/Pills, Powder, Liquid, Others)
2. By Ingredient Type (Vitamins Minerals, Amino Acids, Botanical Supplements, Others)
3. By Distribution Channel (Pharmacies Drug Stores, Specialty Stores, Online, Other)
4. By End-User (Men, Women, Children)
5. By Region (North America, Europe, Asia-Pacific, Rest of the World)
6. By Company (Bayer AG, Procter Gamble Co, Amway India Enterprises Pvt. Ltd., BASF SE, Archer-Daniels-Midland Co, Pfizer Inc, Reckitt Benckiser Group Plc, Vita Life Sciences Limited, Arazo Nutrition, Glanbia plc.)

Key questions answered in the study:

1. What are the current and future trends of the global bone and joint health supplements industry?
2. How the industry has been evolving in terms of form, ingredient type, distribution channel, and end-users?
3. How the competition has been shaping across the countries followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the global bone and joint health supplements industry?
5. What is the customer orientation, purchase behavior, and expectations from the global bone and joint health supplements suppliers across various region and countries?